UCSF’s Program in Craniofacial Biology (PCB) brings together researchers to study the cellular and molecular mechanisms ...

Nothing can trigger a memory so unexpectedly as an aroma. Clove oil immediately transports you to the dentist’s office. Crayola crayons take you back to elementary school. But some fragrances are ...

Millennials had the “do nothing”—a smooth-brained consumer, existing without thriving or contributing. Gen Z’s version seems ...

Rutgers students in the School of Communication and Information presented their work in "InfoViz," an exhibition that ...

I spent a day or so recovering from a curling bonspiel known as the Bulldog. The Bulldog is an old-school men’s ’spiel, held ...

In reviewing my 2025 columns, I came across several that explored the humorous side of living in Hawaii. Here are some of the ...

Derrick Johnson II was the only corner the Sooners signed, but the 4-star recruit was rated as the No. 23 cornerback by ...

The Kennedy Center has officially embraced its first post-“woke” class of honorees. Over the summer, Donald Trump announced ...

Discover the Korean dramas of 2025 with the highest rating on IMDb. From ‘Bon Appétit, Your Majesty’ to ‘Weak Hero Class 2’, ...

Every face is unique. Genetics helps to determine our features, but sometimes genes have errors, which, in early fetal development, can result in ...

Phase 2 Clinical Data Highlights: Hemab's Phase 2 study of sutacimig (N=34) is intended to address a profound gap in care for GT as there are currently no effective prophylactic treatment options.

If you have read this column before, you have likely noticed my anti-technology paranoia. I have written a lot about the harm ...